Some of the best series available on Netflix were developed outside Hollywood, showcasing the potential of foreign language ...

DM1 results from a CTG repeat expansion in the DMPK gene, with disease severity linked to the number of repeats (symptoms ...

Pursuant to the terms of the Agreement, Lupin will not market its generic version of FIRDAPSE in the United States any earlier than February 25, 2035, if approved by the U.S. Food and Drug ...

As part of the settlement, Lupin will receive a license to market generic Firdapse beginning in February 2035.

Catalyst Pharma ( ($CPRX) ) has shared an announcement. On August 25, 2025, Catalyst Pharmaceuticals and its licensor SERB S.A. announced a ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

This isn’t some fever dream induced by too much sunshine – it’s one of Florida’s most spectacular roadside attractions, a bronze behemoth that has become an unlikely pilgrimage site for travelers ...

We’ve rounded up the top four most dangerous species below. Introduced in Harry Potter and the Chamber of Secrets, the ...

The Harry Potter HBO show has the opportunity to highlight some of the darker elements of the Wizarding World.